阅读说明：本技术 Cdk4/6抑制剂与egfr抑制剂联合在制备***疾病的药物中的用途 (Use of CDK4/6 inhibitor in combination with EGFR inhibitor for the manufacture of a medicament for the treatment of neoplastic diseases ) 是由 张蕾 杨昌永 廖成 张连山 于 2019-05-22 设计创作，主要内容包括：本发明提供了CDK4/6抑制剂与EGFR抑制剂联合在制备治疗肿瘤疾病的药物中的用途。具体而言,本发明提供一种细胞周期蛋白依赖性激酶4和6抑制剂(CDK4/6i)与人表皮生长因子受体抑制剂(EGFRi)联合在制备预防或治疗肿瘤疾病的药物中的用途。(The invention provides the use of a CDK4/6 inhibitor in combination with an EGFR inhibitor for the manufacture of a medicament for the treatment of a neoplastic disease. In particular, the invention provides the use of a cyclin-dependent kinase 4 and 6 inhibitor (CDK4/6i) in combination with a human Epidermal Growth Factor Receptor Inhibitor (EGFRI) for the preparation of a medicament for the prevention or treatment of a neoplastic disease.)